Your browser doesn't support javascript.
loading
Pseudoviruses, a safer toolbox for vaccine development against enveloped viruses.
Thimmiraju, Syamala R; Kimata, Jason T; Pollet, Jeroen.
Afiliación
  • Thimmiraju SR; Department of Pediatrics, Section of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA.
  • Kimata JT; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, TX, USA.
  • Pollet J; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
Expert Rev Vaccines ; 23(1): 174-185, 2024.
Article en En | MEDLINE | ID: mdl-38164690
ABSTRACT

INTRODUCTION:

Pseudoviruses are recombinant, replication-incompetent, viral particles designed to mimic the surface characteristics of native enveloped viruses. They are a safer, and cost-effective research alternative to live viruses. With the potential emergence of the next major infectious disease, more vaccine scientists must become familiar with the pseudovirus platform as a vaccine development tool to mitigate future outbreaks. AREAS COVERED This review aims at vaccine developers to provide a basic understanding of pseudoviruses, list their production methods, and discuss their utility to assess vaccine efficacy against enveloped viral pathogens. We further illustrate their usefulness as wet-lab simulators for emerging mutant variants, and new viruses to help prepare for current and future viral outbreaks, minimizing the need for gain-of-function experiments with highly infectious or lethal enveloped viruses. EXPERT OPINION With this platform, researchers can better understand the role of virus-receptor interactions and entry in infections, prepare for dangerous mutations, and develop effective vaccines.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Virus / Vacunas Límite: Humans Idioma: En Revista: Expert Rev Vaccines Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Virus / Vacunas Límite: Humans Idioma: En Revista: Expert Rev Vaccines Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos